Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 69Prostatic Neoplasms 47Breast Neoplasms 14Sarcoma 10Neoplasms 10Endometrial Neoplasms 9Vaginal Neoplasms 7Esophageal Neoplasms 6Uterine Neoplasms 4Radiation Injuries 4Lung Neoplasms 4Liver Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Vulvar Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Retinoblastoma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Platinum 1Cisplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation × Brachytherapy × Clear all
NCT00492778 2023-03-29

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Unknown
165 enrolled 15 charts
Gynecologic

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡